CMP Pharma, Inc.
9 drugs in NADAC|5 Generic,4 Brand
CMP Pharma, Inc. lists 9 NDCs in the CMS NADAC file (5 generic, 4 brand), at an average NADAC of $2.53 per unit, with a week-over-week move of +1.6% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
9
5G / 4B
Avg Price / Unit
$2.5333
$0.08 – $13.59
Avg 7d Change
+1.61%
Across 6 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Weekly brief
Featured in the latest weekly brief
This manufacturer is surfaced in the latest executive summary of notable weekly NADAC movement.
Lead market
sodium polystyrene sulfonate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Anti-coagulant therapeutic class
Review the broader class where CMP Pharma, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does CMP Pharma, Inc. make?
CMP Pharma, Inc. lists 9 NDCs in the CMS NADAC file — 5 generic and 4 brand products.
What is the average price of CMP Pharma, Inc. drugs?
The average NADAC across CMP Pharma, Inc.'s portfolio is $2.5333 per unit, ranging from $0.0768 to $13.5931.
What types of drugs does CMP Pharma, Inc. make?
CMP Pharma, Inc. makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are Anti-coagulant (2), Calculi Dissolution Agent (2), Phosphodiesterase 5 Inhibitor (1), Aldosterone Antagonist (1), Dihydropyridine Calcium Channel Blocker (1).
Has CMP Pharma, Inc. had any drug recalls?
No FDA enforcement recalls are matched to CMP Pharma, Inc. in the openFDA feed.
How has CMP Pharma, Inc.'s pricing changed recently?
Over the past 7 days, 5 CMP Pharma, Inc. products rose and 1 fell, with a portfolio-wide average change of +1.6%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TADLIQ 20 MG/5 ML SUSPENSION Tadalafil | $13.5931 per ML | +4.00% |
CAROSPIR 25 MG/5 ML SUSPENSION CaroSpir | $3.4521 per ML | — |
NORLIQVA 1 MG/ML SOLUTION amlodipine | $3.2172 per ML | +0.06% |
ATORVALIQ 20 MG/5 ML SUSP ATORVALIQ | $1.2348 per ML | +4.00% |
SPS 15 GM/60 ML SUSPENSION sodium polystyrene sulfonate | $0.4380 per ML | +0.32% |
SPS 15 GM/60 ML SUSPENSION sodium polystyrene sulfonate | $0.3851 per ML | — |
ISONIAZID 50 MG/5 ML SOLUTION isoniazid | $0.3100 per ML | — |
SODIUM POLYSTYRENE SULF POWDER Sodium Polystyrene Sulfonate | $0.0924 per GM | -2.67% |
ORACIT ORAL SOLUTION Citric Acid and Sodium Citrate | $0.0768 per ML | +3.97% |